Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
11725 | 959 | 33.1 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
99 | 3 | HEPATITIS C VIRUS//HEPATITIS C//HEPATITIS B VIRUS | 74452 |
1696 | 2 | NONALCOHOLIC FATTY LIVER DISEASE//NON ALCOHOLIC FATTY LIVER DISEASE//NONALCOHOLIC STEATOHEPATITIS | 6749 |
11725 | 1 | GAMMA GLUTAMYLTRANSFERASE//GAMMA GLUTAMYL TRANSFERASE//ALANINE AMINOTRANSFERASE | 959 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GAMMA GLUTAMYLTRANSFERASE | authKW | 1905887 | 16% | 38% | 158 |
2 | GAMMA GLUTAMYL TRANSFERASE | authKW | 525365 | 7% | 25% | 67 |
3 | ALANINE AMINOTRANSFERASE | authKW | 380222 | 10% | 12% | 100 |
4 | SERUM GAMMA GLUTAMYL TRANSFERASE | authKW | 289447 | 1% | 91% | 10 |
5 | GAMMA GLUTAMYLTRANSFERASE FRACTIONS | authKW | 254715 | 1% | 100% | 8 |
6 | GGT | authKW | 203935 | 3% | 21% | 31 |
7 | GAMMA GLUTAMYLTRANSFERASE ACTIVITY | authKW | 132662 | 1% | 83% | 5 |
8 | GAMMA GLUTAMYL TRANSFERASE GGT | authKW | 122447 | 1% | 38% | 10 |
9 | GAMMA GLUTAMYLTRANFERASE | authKW | 95518 | 0% | 100% | 3 |
10 | LIVER ENZYMES | authKW | 71100 | 3% | 7% | 31 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Gastroenterology & Hepatology | 2034 | 14% | 0% | 139 |
2 | Medical Laboratory Technology | 1456 | 7% | 0% | 64 |
3 | Endocrinology & Metabolism | 1342 | 15% | 0% | 147 |
4 | Peripheral Vascular Diseases | 1005 | 10% | 0% | 97 |
5 | Medicine, General & Internal | 796 | 15% | 0% | 140 |
6 | Cardiac & Cardiovascular System | 499 | 10% | 0% | 97 |
7 | Primary Health Care | 239 | 2% | 0% | 16 |
8 | Medicine, Research & Experimental | 237 | 7% | 0% | 67 |
9 | Nutrition & Dietetics | 175 | 4% | 0% | 40 |
10 | Public, Environmental & Occupational Health | 169 | 7% | 0% | 65 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HEPATITIS C PROGRAMS | 63679 | 0% | 100% | 2 |
2 | ULCH UCL NIHR BIOMED | 63679 | 0% | 100% | 2 |
3 | AGREGAR FARMACOL | 31839 | 0% | 100% | 1 |
4 | AIZAHRA HOSP | 31839 | 0% | 100% | 1 |
5 | ANESTHESIOL SERV REANIMAC | 31839 | 0% | 100% | 1 |
6 | ARASTIIMA UYGULAMA HASTANESITIP FAK | 31839 | 0% | 100% | 1 |
7 | CANYGE HALL | 31839 | 0% | 100% | 1 |
8 | CARCICNOGENESIS CANC INVAS | 31839 | 0% | 100% | 1 |
9 | CARDIOVASC EPIDEMIOL UNIT CLIN MED | 31839 | 0% | 100% | 1 |
10 | CARDIOVASC MED CLIN CHEM | 31839 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | METABOLIC SYNDROME AND RELATED DISORDERS | 2556 | 1% | 1% | 7 |
2 | ATHEROSCLEROSIS | 2482 | 3% | 0% | 29 |
3 | JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS | 1812 | 1% | 1% | 8 |
4 | LIVER INTERNATIONAL | 1238 | 1% | 0% | 10 |
5 | CORONARY ARTERY DISEASE | 1004 | 1% | 0% | 9 |
6 | CARDIOVASCULAR DIABETOLOGY | 916 | 1% | 0% | 6 |
7 | ANGIOLOGY | 823 | 1% | 0% | 11 |
8 | DIABETIC MEDICINE | 786 | 1% | 0% | 12 |
9 | LABORATORNOE DELO | 636 | 0% | 1% | 4 |
10 | CLINICS IN LIVER DISEASE | 620 | 0% | 1% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BULUSU, S , SHARMA, M , (2016) WHAT DOES SERUM -GLUTAMYLTRANSFERASE TELL US AS A CARDIOMETABOLIC RISK MARKER?.ANNALS OF CLINICAL BIOCHEMISTRY. VOL. 53. ISSUE 3. P. 312 -332 | 76 | 76% | 0 |
2 | LIOUDAKI, E , GANOTAKIS, ES , MIKHAILIDIS, DP , (2011) LIVER ENZYMES: POTENTIAL CARDIOVASCULAR RISK MARKERS?.CURRENT PHARMACEUTICAL DESIGN. VOL. 17. ISSUE 33. P. 3632-3643 | 67 | 68% | 25 |
3 | BALLESTRI, S , ZONA, S , TARGHER, G , ROMAGNOLI, D , BALDELLI, E , NASCIMBENI, F , ROVERATO, A , GUARALDI, G , LONARDO, A , (2016) NONALCOHOLIC FATTY LIVER DISEASE IS ASSOCIATED WITH AN ALMOST TWOFOLD INCREASED RISK OF INCIDENT TYPE 2 DIABETES AND METABOLIC SYNDROME. EVIDENCE FROM A SYSTEMATIC REVIEW AND META-ANALYSIS.JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. VOL. 31. ISSUE 5. P. 936 -944 | 36 | 51% | 21 |
4 | RUHL, CE , EVERHART, JE , (2009) ELEVATED SERUM ALANINE AMINOTRANSFERASE AND GAMMA-GLUTAMYLTRANSFERASE AND MORTALITY IN THE UNITED STATES POPULATION.GASTROENTEROLOGY. VOL. 136. ISSUE 2. P. 477-485 | 36 | 69% | 136 |
5 | JIANG, SY , JIANG, DL , TAO, YJ , (2013) ROLE OF GAMMA-GLUTAMYLTRANSFERASE IN CARDIOVASCULAR DISEASES.EXPERIMENTAL & CLINICAL CARDIOLOGY. VOL. 18. ISSUE 1. P. 53-56 | 28 | 88% | 21 |
6 | TARGHER, G , (2010) ELEVATED SERUM GAMMA-GLUTAMYLTRANSFERASE ACTIVITY IS ASSOCIATED WITH INCREASED RISK OF MORTALITY, INCIDENT TYPE 2 DIABETES, CARDIOVASCULAR EVENTS, CHRONIC KIDNEY DISEASE AND CANCER - A NARRATIVE REVIEW.CLINICAL CHEMISTRY AND LABORATORY MEDICINE. VOL. 48. ISSUE 2. P. 147 -157 | 36 | 72% | 43 |
7 | FISHER, L , SRIKUSALANUKUL, W , FISHER, A , SMITH, P , (2015) LIVER FUNCTION PARAMETERS IN HIP FRACTURE PATIENTS: RELATIONS TO AGE, ADIPOKINES, COMORBIDITIES AND OUTCOMES.INTERNATIONAL JOURNAL OF MEDICAL SCIENCES. VOL. 12. ISSUE 2. P. 100 -115 | 67 | 33% | 0 |
8 | LEE, DS , EVANS, JC , ROBINS, SJ , WILSON, PW , ALBANO, I , FOX, CS , WANG, TJ , BENJAMIN, EJ , D'AGOSTINO, RB , VASAN, RS , (2007) GAMMA GLUTAMYL TRANSFERASE AND METABOLIC SYNDROME, CARDIOVASCULAR DISEASE, AND MORTALITY RISK - THE FRAMINGHAM HEART STUDY.ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. VOL. 27. ISSUE 1. P. 127-133 | 25 | 71% | 252 |
9 | LAM, KSL , LAM, TH , SHAM, PC , CHERNY, SS , TSO, AWK , ONG, KL , CHEUNG, BMY , (2011) GAMMA-GLUTAMYL TRANSFERASE LEVEL PREDICTS THE DEVELOPMENT OF HYPERTENSION IN HONG KONG CHINESE.CLINICA CHIMICA ACTA. VOL. 412. ISSUE 15-16. P. 1326-1331 | 29 | 76% | 15 |
10 | KUNUTSOR, SK , (2016) GAMMA-GLUTAMYLTRANSFERASE-FRIEND OR FOE WITHIN?.LIVER INTERNATIONAL. VOL. 36. ISSUE 12. P. 1723 -1734 | 49 | 42% | 0 |
Classes with closest relation at Level 1 |